VCAN and neoplasm: We have now demonstrated tumor growth inhibition in vitro and in vivo with short term ACC cell cultures following depletion of VCAN and the generation of new validated immortalized ACC tumor cell lines and animal models will allow preclinical testing of these new promising extracellular targets for development of new treatment strategies.